JPRN-UMIN000001687Completed未知
A pilot randomized placebo controlled study of the Neutrophil Elastase Inhibitor, Sivelestat, in Patients Undergoing Cardiac Surgery - A pilot randomized placebo controlled study of the Neutrophil Elastase Inhibitor, Sivelestat, in Patients Undergoing Cardiac Surgery
agoya University Hospital Department of Cardiac Surgery0 sites20 target enrollmentStarted: February 5, 2009Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 20
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients requiring either preoperative intravenous inotropic or vasodilative drugs, intraaortic balloon support, supplemental oxygen, or mechanical ventilation
Investigators
Similar Trials
Completed
Phase 2
The safety and efficacy of a locally available probiotic in premature infants.ACTRN12609000374268Womens and Childrens Health Service120
Not yet recruiting
Phase 3
The study is being done to see whether probiotic (good bacteria) if given to children with autism spectrum disorder has any role to play in improving behaviour and gastro-intestinal symptoms in childreCTRI/2021/11/038213utri Newron Pediatrix Private limited
Not yet recruiting
Phase 4
A study to assess the effect of 3-month therapy of Ubidecarenone in treating cancer drug induced muscle wasting.CTRI/2022/11/047338ADITYA VIKRAM SINGH
Completed
Phase 2
A single blind, placebo controlled pilot study to explore the safety and tolerability of a single oral dose of 30 mg BAY 1067197 in patients with chronic heart failure on the background of preexisting beta-blocker therapyheart failurecongestive heart failure10019280NL-OMON38750Bayer10
Active, not recruiting
Phase 1
Pilot study to assess the safety of BAY 1067197 in stable heart failure patients on standard therapy including ß-blockerMedDRA version: 16.1 Level: LLT Classification code 10019279 Term: Heart failure System Organ Class: 100000004849Heart failureEUCTR2013-001287-34-NLBayer HealthCare AG11